Analisis Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe II Dengan Kompetensi Hipertensi Di RS Kota Pekanbaru

Ayu Rahmawati; Nursyafni Lubis; Nawwar Irfan; Muhammad Arif; Putri Afriani

Authors

Ayu Rahmawati Program Studi Farmasi, Universitas Muhammadiyah Riau, Pekanbaru, Indonesia
Nursyafni Lubis Program Studi Farmasi, Universitas Muhammadiyah Riau, Pekanbaru, Indonesia
Nawwar Irfan Program Studi Farmasi, Universitas Muhammadiyah Riau, Pekanbaru, Indonesia
Muhammad Arif Program Studi Farmasi, Universitas Muhammadiyah Riau, Pekanbaru, Indonesia
Putri Afriani Program Studi Farmasi, Universitas Muhammadiyah Riau, Pekanbaru, Indonesia

Keywords: Type 2 Diabetes Mellitus, Hypertension, Potential drug interactions

Abstract

Patients with type 2 Diabetes Mellitus accompanied by hypertension commonly receive multiple medications, increasing the risk of polypharmacy and potential drug interactions. This study aimed to analyze the relationship between the number of drugs used and the occurrence of potential drug interactions among patients with type 2 Diabetes Mellitus and hypertension at Hospital Ini Pekanbaru City. This study employed a non-experimental observational design with retrospective data collection. Samples were selected using purposive sampling, and data were analyzed using IBM SPSS Statistics version 27. A total of 98 medical records met the inclusion criteria. The results showed that 57 patients experienced potential drug interactions, with a total of 67 interaction events. All identified interactions were classified as moderate in severity (100%). Based on the interaction mechanisms, pharmacodynamic interactions were predominant, accounting for 64 events (95.52%), while pharmacokinetic interactions accounted for 3 events (4.48%). Statistical analysis demonstrated a significant association between the number of drugs prescribed and the occurrence of potential drug interactions (p = 0.001). Close monitoring of potential drug interactions is essential to ensure the effectiveness and safety of therapy, particularly in patients undergoing polypharmacy.

Downloads

Download data is not yet available.

References

American Diabetes Association (ADA). (2024). Standards of medical care in diabetes—2024. Diabetes Care, 47(Supplement 1), S1-S321. https://doi.org/10.2337/dc24-S001

Baxter, K. (2010). Stockley's Drug Interactions Ninth Edition. Pharmaceutical Press.

Bintang, S. A. K., Zulkifli, M., & Ningsih, S. (2022). Evaluasi penggunaan obat antidiabetes pada pasien diabetes melitus tipe 2 rawat jalan di RSUD Provinsi Nusa Tenggara Barat. Jurnal Farmasi Klinis Indonesia, 11(2), 120–130. https://doi.org/10.15416/ijcp.2022.11.2.120

Dinas Kesehatan Provinsi Riau. (2020). Profil Kesehatan Provinsi Riau.

Drugs.com. (2025). Drugs Interaction Checker.

Fitriyani, Zannah, M., & Nazarudin, M. (2024). Literature Review: Kajian Potensi Interaksi Obat Antidiabetes Pada Pasien Diabetes Melitus Tipe 2 Dengan Komplikasi Hipertensi. Sains Medisina, 2(3), 93-98.

Hardianto, D. (2021). Telaah Komprehensif Diabetes Melitus: Klasifikasi, Gejala, Diagnosis, Pencegahan, Dan Pengobatan. Jurnal Bioteknologi & Biosains Indonesia (JBBI), 7(2), 304-317.

International Diabetes Federation (IDF). (2021). International Diabetes Federation Diabetes Atlas (10th ed.).

Isnaini, N., & Friadi, A. (2020). Faktor risiko kejadian diabetes melitus tipe 2 di wilayah kerja Puskesmas Kecamatan Syiah Kuala Kota Banda Aceh. Jurnal Sains Riset, 10(1), 11-18.

Kemenkes RI. (2021). Laporan nasional riset kesehatan dasar (Riskesdas) 2018. Badan Penelitian dan Pengembangan Kesehatan.

Lestari, W., Akrom, A., & Darmawan, E. (2023). Analisis potensi interaksi obat antidiabetes dan antihipertensi pada pasien Prolanis di Puskesmas Jetis 1 Bantul. Pharmaciana, 13(1), 89-98. https://doi.org/10.12928/pharmaciana.v13i1.25412

Madania, Rasdianah, N., Dalu, M. C., & Pakaya, M. (2022). Potensi Interaksi Obat Pasien Hipertensi dan Diabetes Melitus tipe 2 di Instalasi Rawat Jalan RSUD Toto Kabila. Pharmacoscript, 5(1), 1-12.

Maimanah, S., Andarini, Y. D., & Kusumaningtyas, N. M. (2022). Identifikasi Drug Related Problems (DRPs) Pada Pasien Diabetes Mellitus Tipe 2 Komplikasi Hipertensi Di Rsup Dr Soeradji Tirtonegoro Klaten Tahun 2018. Pharmaceutical Journal Of Islamic Pharmacy, 4(2), 48-56.

Medscape.com. (2025). Drug Interaction Checker.

Nurjannah, M., & Asthiningsih, N. W. W. (2023). Hipoglikemi pada Penderita Diabetes Mellitus Tipe 2. Jawa Tengah: Pena Persada.

Parulian, L., et al. (2019). Analisis Hubungan Polifarmasi dan Interaksi Obat pada Pasien Rawat Jalan yang Mendapat Obat Hipertensi di RSP. Dr. Ario Wirawan Periode Januari-Maret 2019. Indonesian Journal of Pharmacy and Natural Product, 2(2), 4-7.

PERKENI. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. PB. Perkeni.

Rasdianah, N., Widya, R., & Tukan, P. (2021). Profil penggunaan obat antidiabetes pada pasien diabetes melitus tipe 2 di Instalasi Rawat Jalan RSUD Undata Palu. Jurnal Farmasi Galenika, 7(1), 55-64.

Reyaan, I. B. M., Kuning, C., & Adnyana, I. K. (2021). Studi Potensi Interaksi Obat pada Resep Polifarmasi di Dua Apotek Kota Bandung. Journal Of Management And Pharmacy Practice, 11(3), 145.

Sengaji, M., Ramdani, A., & Hidayat, T. (2023). Kajian interaksi obat pada pasien diabetes melitus tipe 2 dengan hipertensi di RSUD Dr. H. Chasan Boesoirie Ternate. Jurnal Ilmiah Farmasi, 19(1), 12-21. https://doi.org/10.20885/jif.vol19.iss1.art2

Siregar, D. P., & Amalia, R. (2022). Identifikasi Drug Related Problems (DRPs) pada pasien diabetes melitus tipe 2 di Rumah Sakit Umum Daerah Deli Serdang. Jurnal Sains Farmasi & Klinis, 9(2), 145-152. https://doi.org/10.25077/jsfk.9.2.145-152.2022

Analisis Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe II Dengan Kompetensi Hipertensi Di RS Kota Pekanbaru

Authors

Abstract

Downloads

References

Downloads

Published

How to Cite

Issue

Section

License

Most read articles by the same author(s)

Make a Submission

Developed By